The plateau outward current in canine ventricle, sensitive to 4‐aminopyridine, is a constitutive contributor to ventricular repolarization
- 1 November 2007
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 152 (6) , 870-879
Abstract
Background and purpose: IKur (Ultra‐rapid delayed rectifier current) has μM sensitivity to 4‐aminopyridine (4‐AP) and is an important modulator of the plateau amplitude and action potential duration in canine atria. Kv1.5 encodes IKur and is present in both atria and ventricles in canines and humans. We hypothesized that a similar plateau outward current with μM sensitivity to 4‐AP is present in canine ventricle.Experimental approach: We used established voltage clamp protocols and used 4‐AP (50 and 100 μM) to measure a plateau outward current in normal canine myocytes isolated from the left ventricular mid‐myocardium.Key results: Action potential recordings in the presence of 4‐AP showed significant prolongation of action potential duration at 50 and 90% repolarization at 0.5 and 1 Hz (PKur, in ∼70% of left ventricular myocytes. The IC50 of 4‐AP for this current was 24.2 μM. The concentration of 4‐AP used in our experiments resulted in selective blockade of an outward current that was not Ito or IKr. β‐Adrenergic stimulation with isoprenaline significantly increased the 4‐AP sensitive outward current density (PIn silico incorporation into a canine ventricular cell model revealed selective AP prolongation after current blockade.Conclusions and implications: Our results support the existence of a canine ventricular plateau outward current sensitive to micromolar 4‐AP and its constitutive role in ventricular repolarization.British Journal of Pharmacology (2007) 152, 870–879; doi:10.1038/sj.bjp.0707403; published online 13 August 2007Keywords
This publication has 39 references indexed in Scilit:
- Blockade of atrial-specific K+-currents increases atrial but not ventricular contractility by enhancing reverse mode Na+/Ca2+-exchangeCardiovascular Research, 2007
- Gene expression profiling of human cardiac potassium and sodium channelsInternational Journal of Cardiology, 2006
- Novel, Potent Inhibitors of Human Kv1.5 K+ Channels and Ultrarapidly Activating Delayed Rectifier Potassium CurrentThe Journal of Pharmacology and Experimental Therapeutics, 2006
- In Vivo Antiarrhythmic and Cardiac Electrophysiologic Effects of a Novel Diphenylphosphine Oxide IKur Blocker (2-Isopropyl-5-methylcyclohexyl) Diphenylphosphine OxideThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Drug therapy for atrial fibrillation: where do we go from here?Nature Reviews Drug Discovery, 2005
- Dynamic remodeling of K+ and Ca2+ currents in cells that survived in the epicardial border zone of canine healed infarcted heartAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Kv1.5 Is an Important Component of Repolarizing K + Current in Canine Atrial MyocytesCirculation Research, 2003
- Accumulation of slowly activating delayed rectifier potassium current (IKs) in canine ventricular myocytesThe Journal of Physiology, 2003
- Accumulation of slowly activating delayed rectifier potassium current (IKs) in canine ventricular myocytesThe Journal of Physiology, 2003
- Localization of the Kv1.5 K+ channel protein in explanted cardiac tissue.Journal of Clinical Investigation, 1995